These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25586101)

  • 1. The messenger's great message for vaccination.
    Pascolo S
    Expert Rev Vaccines; 2015 Feb; 14(2):153-6. PubMed ID: 25586101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ReNAissanCe of mRNA-based cancer therapy.
    Van Lint S; Renmans D; Broos K; Dewitte H; Lentacker I; Heirman C; Breckpot K; Thielemans K
    Expert Rev Vaccines; 2015 Feb; 14(2):235-51. PubMed ID: 25263094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-based mRNA vaccine delivery systems.
    Midoux P; Pichon C
    Expert Rev Vaccines; 2015 Feb; 14(2):221-34. PubMed ID: 25540984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmid DNA- and messenger RNA-based anti-cancer vaccination.
    Weide B; Garbe C; Rammensee HG; Pascolo S
    Immunol Lett; 2008 Jan; 115(1):33-42. PubMed ID: 18006079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Messenger RNA (mRNA) nanoparticle tumour vaccination.
    Phua KK; Nair SK; Leong KW
    Nanoscale; 2014 Jul; 6(14):7715-29. PubMed ID: 24904987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mRNA transcript therapy.
    Weissman D
    Expert Rev Vaccines; 2015 Feb; 14(2):265-81. PubMed ID: 25359562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Messenger RNA-based vaccines.
    Pascolo S
    Expert Opin Biol Ther; 2004 Aug; 4(8):1285-94. PubMed ID: 15268662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mRNA-based dendritic cell vaccines.
    Benteyn D; Heirman C; Bonehill A; Thielemans K; Breckpot K
    Expert Rev Vaccines; 2015 Feb; 14(2):161-76. PubMed ID: 25196947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress on new vaccine strategies for the immunotherapy and prevention of cancer.
    Berzofsky JA; Terabe M; Oh S; Belyakov IM; Ahlers JD; Janik JE; Morris JC
    J Clin Invest; 2004 Jun; 113(11):1515-25. PubMed ID: 15173875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and advances towards the rational design of mRNA vaccines.
    Pollard C; De Koker S; Saelens X; Vanham G; Grooten J
    Trends Mol Med; 2013 Dec; 19(12):705-13. PubMed ID: 24138818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Messenger RNA vaccine based on recombinant MS2 virus-like particles against prostate cancer.
    Li J; Sun Y; Jia T; Zhang R; Zhang K; Wang L
    Int J Cancer; 2014 Apr; 134(7):1683-94. PubMed ID: 24105486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The European Regulatory Environment of RNA-Based Vaccines.
    Hinz T; Kallen K; Britten CM; Flamion B; Granzer U; Hoos A; Huber C; Khleif S; Kreiter S; Rammensee HG; Sahin U; Singh-Jasuja H; Türeci Ö; Kalinke U
    Methods Mol Biol; 2017; 1499():203-222. PubMed ID: 27987152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity.
    Fotin-Mleczek M; Duchardt KM; Lorenz C; Pfeiffer R; Ojkić-Zrna S; Probst J; Kallen KJ
    J Immunother; 2011 Jan; 34(1):1-15. PubMed ID: 21150709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mRNA: A Versatile Molecule for Cancer Vaccines.
    Diken M; Kranz LM; Kreiter S; Sahin U
    Curr Issues Mol Biol; 2017; 22():113-128. PubMed ID: 27801664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The form of NY-ESO-1 antigen has an impact on the clinical efficacy of anti-tumor vaccination.
    Parvanova I; Rettig L; Knuth A; Pascolo S
    Vaccine; 2011 May; 29(22):3832-6. PubMed ID: 21470580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect.
    Fotin-Mleczek M; Zanzinger K; Heidenreich R; Lorenz C; Thess A; Duchardt KM; Kallen KJ
    J Gene Med; 2012 Jun; 14(6):428-39. PubMed ID: 22262664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active vaccination after allogeneic bone marrow cell transplantation: a new option in the immunotherapy of cancer?
    Zöller M; Matzku S
    Arch Immunol Ther Exp (Warsz); 2002; 50(3):197-224. PubMed ID: 12098935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination.
    Tombácz I; Weissman D; Pardi N
    Methods Mol Biol; 2021; 2197():13-31. PubMed ID: 32827130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and Evaluation of Prophylactic mRNA Vaccines Against Allergy.
    Weiss R; Scheiblhofer S; Thalhamer J
    Methods Mol Biol; 2017; 1499():123-139. PubMed ID: 27987146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA vaccines: successes and limitations in cancer and infectious disease.
    Lowe DB; Shearer MH; Kennedy RC
    J Cell Biochem; 2006 May; 98(2):235-42. PubMed ID: 16440328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.